Skip to content

Positive Communication and Clinical Performance in Anaesthetic Care.

Positive Communication Within Healthcare Team and Clinical Performance: a Prospective, Randomised and Controlled Simulation Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03375073
Acronym
ComPerf
Enrollment
32
Registered
2017-12-15
Start date
2017-11-29
Completion date
2018-09-29
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesiology, Clinical Performance, High Fidelity Simulation, Positive Communication

Brief summary

The emotional and cognitive impact of positive communication between caregivers remains uninvestigated. The investigators hypothesize that positive communication during medical transmission can increase clinical performance for managing a subsequent stressful unexpected adverse event.

Detailed description

When caregivers deal with acute stressful adverse events, cognitive overload and negative emotions can impair cognitive abilities and decrease clinical performance. The beneficial effect of positive communication on patients' emotions has widely been studied. However, the emotional and cognitive impact of positive communication between caregivers remains uninvestigated. The primary purpose of this trial is to study the impact of positive communication between anaesthetic teams during medical transmissions on clinical performance for managing a subsequent stressful unexpected adverse event. Secondary outcomes are to study the impact of positive communication on physiological (heart rate variability) and psychological (psychometric scales) levels of stress.

Interventions

OTHERPositive communication during medical transmission

Use of positive communication for medical transmission to the anaesthetic team who takes over the patient.

Sponsors

University Grenoble Alps
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Randomized controlled trial, with a 1:1 allocation ratio

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Anaesthetic teams composed with : * 1 resident in anaesthesiology and critical care AND * 1 anaesthetic nursing student in second year OR 1 anaesthetic nurse graduated less than 5 years ago Non-inclusion criteria * Refusal to be videotaped * No consent to participate * Anaesthetic nurses working in a paediatric operating room.

Design outcomes

Primary

MeasureTime frameDescription
Clinical performance of the anaesthetic teamEach anaesthetic team will be involved once in the scenario. The scenario will last about 6 min (transmission not included). Both assessment of clinical performance will be made within 20 weeks of each simulation sessionClinical performance in a simulated scenario of laryngospasm occurring in a 7 year old child under general anaesthesia. Clinical performance will be scored from 0 to 100 by two independent blinded assessors, using video records and a pre-established scenario-specific checklist. The primary endpoint will be the mean of the two assessments for each performance.

Secondary

MeasureTime frameDescription
Heart rate variabilityBefore the scenario (during 5 min), during medical transmission (2 min), during the scenario before the laryngospasm (2 min), during the laryngospasm (4 min), during the debriefing (20 min), after the debriefing (5 min)Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants
Self-reported stressBefore the scenario (at 5 min), after medical transmission (at 7 min), after the scenario (at 13 min), after debriefing (at 33 min)Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026